CTI BioPharma Corp. (Nasdaq: CTIC) today announced an oral presentation and two poster presentations from the Company's pacritinib program at the 64th American Society of Hematology (ASH®) Annual...

Blueprint Medicines Corporation (NASDAQ: BPMC) today announced the acceptance of abstracts highlighting long-term clinical outcomes and impact on overall survival of AYVAKIT® (avapritinib) in...

-- ASH abstract contains previously presented data from June 2022 -- -- New clinical data from a recent data cut will be presented at ASH -- -- Company to host a live webcast event with an expert...

Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the...

Lennox International Inc. (NYSE: LII), a leader in energy-efficient climate-control solutions, today announced that CEO Alok Maskara and CFO Joe Reitmeier are scheduled to present at the Baird...

Loxo@Lilly, the oncology unit of Eli Lilly and Company (NYSE: LLY), today announced that study investigators will present data from the BRUIN Phase 1/2 trial of pirtobrutinib at the American...

The 2nd Global Forum of People's Organizations on Hansen's Disease takes place in Hyderabad, India, from November 6 to 8, 2022. Organized by Sasakawa Leprosy (Hansen's Disease) Initiative as part...

Disc Medicine, a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases,...

Real-world analysis findings highlight overall survival benefit in adolescent and young adult (AYA) newly-diagnosed acute lymphoblastic leukemia (ALL) patients treated with pediatric-inspired...

Premium Cannabis Product Brand Recognized in Four Categories in Arizona's Largest Cannabis Awards Program PHOENIX, Nov. 3, 2022 /PRNewswire/ -- Item 9 Labs—the award-winning, premium cannabis...